Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

NCT02113878 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell of Head and Neck
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Hypopharyngeal Cancer
Early Invasive Cervical Squamous Cell Carcinoma
Carcinoma of Larynx
Cancer of Nasopharynx

Interventions

DRUG: BKM120
DRUG: Cisplatin
RADIATION: Intensity-modulated radiotherapy (IMRT)

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]